Q2 2015 13F Holders as of 6/30/2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
531
-
Total 13F shares, excl. options
-
72.9M
-
Shares change
-
+750K
-
Total reported value, excl. options
-
$37.2B
-
Value change
-
+$405M
-
Put/Call ratio
-
1.39
-
Number of buys
-
242
-
Number of sells
-
-238
-
Price
-
$510.13
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2015
604 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q2 2015.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 531 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 72.9M shares
of 105M outstanding shares and own 69.4% of the company stock.
Largest 10 shareholders include Capital World Investors (7.96M shares), FMR LLC (5.93M shares), WELLINGTON MANAGEMENT GROUP LLP (5.5M shares), VANGUARD GROUP INC (4.3M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.25M shares), SANDS CAPITAL MANAGEMENT, LLC (4.22M shares), STATE STREET CORP (3.02M shares), JPMORGAN CHASE & CO (2.44M shares), BlackRock Fund Advisors (2.12M shares), and Artisan Partners Limited Partnership (2.08M shares).
This table shows the top 531 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.